{"transactions":[{"id":4637931,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-08T20:40:07.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"225 shares will vest on each of October 6, 2027, October 6, 2028, and October 6, 2029."}],"balance_after":675,"derivative":{"exercise_price":174.86,"expiration_date":"2036-10-06","underlying":"Common Stock","underlying_shares":675},"source":{"system":"sec-edgar","filing":"0001628280-26-065462","document":"wk-form4_1791492005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104618/000162828026065462/wk-form4_1791492005.xml","form_type":"4"}},{"id":4637930,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-10-08T20:40:07.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Douglass was awarded 700 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":8685,"source":{"system":"sec-edgar","filing":"0001628280-26-065462","document":"wk-form4_1791492005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104618/000162828026065462/wk-form4_1791492005.xml","form_type":"4"}},{"id":787889,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-05-08T18:39:43.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":334,"price":126.43,"value":42227.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":7985,"source":{"system":"sec-edgar","filing":"0001193125-26-214265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526214265/ownership.xml","form_type":"4"}},{"id":872211,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T17:48:01.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":221,"price":124.97,"value":27618.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":8319,"source":{"system":"sec-edgar","filing":"0001193125-26-087447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087447/ownership.xml","form_type":"4"}},{"id":941673,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T21:32:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares will vest in substantially equal installments over a three-year period with each such vesting date occurring on the anniversary of the grant date."}],"balance_after":2143,"derivative":{"exercise_price":163.86,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":2143},"source":{"system":"sec-edgar","filing":"0001193125-26-010470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526010470/ownership.xml","form_type":"4"}},{"id":941672,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-01-12T21:32:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Douglass was awarded 2,288 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in substantially equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock."}],"balance_after":8540,"source":{"system":"sec-edgar","filing":"0001193125-26-010470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526010470/ownership.xml","form_type":"4"}}]}